These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2171040)
1. 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid is a more potent neutrophil chemoattractant than the 12(R) epimer in the rat cornea. Wiggins RE; Jafri MS; Proia AD Prostaglandins; 1990 Aug; 40(2):131-41. PubMed ID: 2171040 [TBL] [Abstract][Full Text] [Related]
2. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events. Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin. Dowd PM; Black AK; Woollard PW; Greaves MW Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751 [TBL] [Abstract][Full Text] [Related]
4. 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid is a chemoattractant for human polymorphonuclear leucocytes in vitro. Cunningham FM; Woollard PM Prostaglandins; 1987 Jul; 34(1):71-8. PubMed ID: 3317516 [TBL] [Abstract][Full Text] [Related]
13. Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium. Takata S; Matsubara M; Allen PG; Janmey PA; Serhan CN; Brady HR J Clin Invest; 1994 Feb; 93(2):499-508. PubMed ID: 7906693 [TBL] [Abstract][Full Text] [Related]
14. 12(R)-hydroxyeicosatetraenoic acid, an endogenous corneal arachidonate metabolite, lowers intraocular pressure in rabbits. Masferrer JL; Dunn MW; Schwartzman ML Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):535-9. PubMed ID: 2318592 [TBL] [Abstract][Full Text] [Related]
15. 6-trans-leukotriene B4 is a neutrophil chemotaxin in the guinea pig dermis. Fretland DJ; Widomski DL; Anglin CP; Walsh RE; Levin S; Gaginella TS J Leukoc Biol; 1991 Mar; 49(3):283-8. PubMed ID: 1847716 [TBL] [Abstract][Full Text] [Related]
16. CD 18 monoclonal antibody inhibits neutrophil diapedesis in the murine dermis induced by leukotriene B4 and 12(R)-hydroxyeicosatetraenoic acid. Fretland D; Widomski D; Anglin C; Gaginella T Eicosanoids; 1990; 3(3):171-4. PubMed ID: 1978685 [TBL] [Abstract][Full Text] [Related]
17. Effects of oxo and dihydro metabolites of 12-hydroxy-5,8,10,14-eicosatetraenoic acid on chemotaxis and cytosolic calcium levels in human neutrophils. Powell WS; Hashefi M; Falck JR; Chauhan K; Rokach J; Wang SS; Mills E; MacLeod RJ J Leukoc Biol; 1995 Feb; 57(2):257-63. PubMed ID: 7852839 [TBL] [Abstract][Full Text] [Related]
18. Response of psoriatic lesions to multiple applications of leukotriene B4 and 12-HETE. Norris PG; Schofield O; Dowd PM; Greaves MW Dermatologica; 1987; 174(5):219-23. PubMed ID: 3034690 [TBL] [Abstract][Full Text] [Related]
19. SC-41930, a leukotriene B4 receptor antagonist, inhibits 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding to epidermal cells. Kemény L; Ruzicka T Agents Actions; 1991 Mar; 32(3-4):339-42. PubMed ID: 1650525 [TBL] [Abstract][Full Text] [Related]
20. 12-Lipoxygenase product as an inhibitor of the action of chemoattractant peptide fMet-Leu-Phe in rat neutrophils. Yoshino H; Kitayama S; Morita K; Okamoto H; Tsujimoto A; Dohi T Gen Pharmacol; 1993 Sep; 24(5):1249-51. PubMed ID: 8270183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]